Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes.

Carriers of mutations in hereditary cancer predisposition genes represent a small but clinically important subgroup of oncology patients. The identification of causal germline mutations determines follow-up management, treatment options and genetic counselling in patients' families. Targeted ne...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jana Soukupova, Petra Zemankova, Klara Lhotova, Marketa Janatova, Marianna Borecka, Lenka Stolarova, Filip Lhota, Lenka Foretova, Eva Machackova, Viktor Stranecky, Spiros Tavandzis, Petra Kleiblova, Michal Vocka, Hana Hartmannova, Katerina Hodanova, Stanislav Kmoch, Zdenek Kleibl
Format: Artigo
Langue:Inglês
Publié: Public Library of Science (PLoS) 2018-01-01
Collection:PLoS ONE
Accès en ligne:http://europepmc.org/articles/PMC5896995?pdf=render
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires